drugset / Trial / NCT00278980

Effect of C-Peptide on Diabetic Peripheral Neuropathy

NCT00278980

Phase 2 Completed 180 enrolled Creative Peptides Sweden Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the study is to investigate the effect of C-peptide administration on nerve function in patients with type 1 diabetes and peripheral sensory neuropathy.

Timeline

Start
2003-10
Primary completion
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject HUMAN C-PEPTIDE Peptide